Diagnostic Value of Optical Enhancement Technology in Early Esophageal Squamous Neoplasia

NCT02851264 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2016-08-01

No results posted yet for this study

Summary

The aims of the present study:

1. To investigate the diagnosing value of optical enhancement technology for early esophageal squamous neoplasia.
2. To assess the detection rate of early esophageal squamous neoplasia by virtual chromoendoscopy with optical enhancement technology .

Conditions

  • Early Esophageal Squamous Neoplasia

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Yanqing Li, MD,PhD · Qilu Hospital of Shandong University

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2017-08-31
Completion
2017-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02851264 on ClinicalTrials.gov